Skip to main content
Caplight Logo









Aikium

Aikium

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.aikium.com/

Last Round

Grant

Jun 23, 2025

Total Funding Raised

$1.6M

Company Overview

Aikium is a biotechnology company that develops protein therapeutics for neuro-inflammation and oncology by leveraging breakthroughs in synthetic biology and deep learning to develop proprietary non-antibody scaffold proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, ML Platforms, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

protein therapeuticsdrug discoveryprotein language modelsgenerative biologybinder discoverysynthetic biologyhigh-throughput screeningundruggable targetsAI-driven drug discoveryprotein engineeringbiotech platformin silico drug designAI-first biotechpLMwet-lab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aikium Comparables

Compare Aikium with similar companies based on industry and business-model similarity.

Aikium comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Topos Bio
79%
A-Alpha Bio
79%
Nabla Bio
78%

Aikium Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 23, 2025
Pre SeedNov 15, 2024

Key People

Founding team and executive leadership

Eswar I.

Co-Founder And CEO, Head Of Synthetic Biology

Founding Team

Michael Tolentino

Co-Founder, Head Scientific Consultant To The CEO

Founding Team

Aikium Investors

Notable investors and investment history

Aikium investors
InvestorRounds
3i PartnersPre Seed
Bantam GroupPre Seed
Civilization VenturesPre Seed
Half Court VenturesPre Seed
Fellows FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 15, 2024

    $1.5M round from 5 venture capital firms

Aikium Filings

Explore SEC and related filing metadata, where available.

Aikium filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aikium's valuation, stock price, and market status.

Is Aikium a public or private company?

Aikium is a private company.

What is the current stock price of Aikium?

Aikium is a private company with no public stock price. No recent secondary market data is available.

How much is Aikium worth (valuation)?

Valuation information for Aikium is not publicly available.

Can I buy Aikium stock?

Aikium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aikium's last funding round?

Aikium's most recent funding round was Pre Seed on November 15, 2024.

Who are the main investors in Aikium?

Key investors in Aikium include 3i Partners, Bantam Group, Civilization Ventures, Fellows Fund.

Will Aikium IPO soon?

No public IPO plans have been announced for Aikium.

How can I track Aikium secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aikium's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Employee Range7
Year Founded2022
Last FundingJun 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?